Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 148, Issue 2, 2010, Pages 195-198

  Fujiwara, Hiroyuki ^a   Konno, Ryo ^a   Netsu, Sachiho ^a   Odagiri, Kohei ^a   Taneichi, Akiyo ^a   Takamizawa, Satoshi ^a   Ohwada, Michitaka ^a   Suzuki, Mitsuaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dysmenorrhea; Leukotriene receptor antagonist; Montelukast; NSAID

Indexed keywords

MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; HUMAN; MENSTRUAL CYCLE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT INDICATION; VISUAL ANALOG SCALE;

EID: 73749086392     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.10.030     Document Type: Article

References (30)

1. Jakschik B.A., Falkenhein S., and Parker C.W. Precursor role of arachidonic acid in the release of a slow-reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci USA 74 (1977) 4577-4581
2. Henderson Jr. W.R. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am Rev Respir Dis 143 (1991) S86-S90
3. Drazen J.M., Israel E., and O'Byrne P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340 (1999) 197-206
4. Figueroa D.J., Breyer R.M., Defoe S.K., et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 163 (2001) 226-233
5. Piper P.J. Pharmacology of leukotrienes. Br Med Bull 39 (1983) 225-259
6. Henderson Jr. W.R. The role of leukotrienes in inflammation. Ann Intern Med 121 (1994) 684-697
7. Storms W., Michele T.M., Knorr B., et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥6 years. Clin Exp Allergy 31 (2001) 77-87
8. Bracken M.B., Triche E.W., Belanger K., Saftlas A., Beckett W.S., and Leaderer B.P. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol 102 (2003) 739-752
9. Bakhireva L.N., Jones K.L., Schatz M., et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 119 (2007) 618-625
10. National Heart, Lung, and Blood Institute, and National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. J Allergy Clin Immunol 115 (2005) 34-46
11. Abu J.I., and Konje J.C. Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update 6 (2000) 200-205
12. Chegini N., and Rao C.V. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue. J Clin Endocrinol Metab 66 (1988) 76-87
13. Demers M.Y., Hahn D.W., and McGuire J.L. Newer concepts in dysmenorrhoea research: leukotrienes and calcium channel blockers. Premenstrual syndrome and dysmenorrhoea (1984), Pitman, London p. 205-213
14. Rees M.C., DiMarzo V., Tippins J.R., Morris H.R., and Turnbull A.C. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. J Endocrinol 113 (1987) 291-295
15. Nigam S., Benedetto C., Zonca M., Leo-Rossberg I., Lubbert H., and Hammerstein J. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 4 (1991) 137-141
16. Levinson S.L. Peptidoleukotriene binding in guinea pig uterine membrane preparations. Prostaglandins 28 (1984) 229-240
17. Benedetto C. Eicosanoids in primary dysmenorrhea, endometriosis, and menstrual migraine. Gynecol Endocrinol 3 (1989) 71-94
18. Konno R., Fujiwara H., and Suzuki M. Effectiveness of leukotriene receptor antagonists for dysmenorrhea and endometriosis. Fam Med 36 (2004) 8-9
19. Harel Z., Riggs S., Vaz R., Flanagan P., and Harel D. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents. J Pediat Adolesc Gynecol 17 (2004) 183-186
20. Lundström V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors-a promising therapeutic alternative. Acta Obstet Gynecol Scand 57 5 (1978) 421-428
21. Telimaa S., Puolakka J., Ronnberg L., and Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1 (1987) 13-23
22. Calhoun W.J., Lavins B.J., Minkwitz M.C., Evans R., Gleich G.J., and Cohn J. Effect of zafirlukast (Accolate) on cellular mediators of inflammation. Am J Respir Crit Med 157 (1998) 1381-1389
23. Hele D.J., Birrell M.A., Webber S.E., Foster M.L., and Belvisi M.G. Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airway of ovalbumin sensitized Brown Norway rats. Br J Pharmacol 132 (2001) 481-488
24. Fujiwara H., Konno R., Netsu S., et al. Localization of mast cells in endometrial cysts. Am J Reprod Immunol 51 (2004) 341-344
25. Harada T., Iwabe T., and Terakawa N. Role of cytokines in endometriosis. Fertil Steril 76 (2001) 1-10
26. Wu M.Y., and Ho H.N. The role of cytokines in endometriosis. Am J Reprod Immunol 49 (2003) 285-296
27. Ihara T., Uchiide I., and Sugamata M. Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis. Fertil Steril 81 (2004) 819-823
28. Drazen J.M., Yandava C.N., Dubé L., et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 22 (1999) 168-170
29. Sampson A.P., Siddiqui S., Buchanan D., et al. Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis eosinophils and predicts clinical response to zafirlukast. Thorax 55 (2000) S28-S31
30. Brandes J.L., Visser W.H., Farmer M.V., et al. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache 44 (2004) 581-586